Introduction to Medpace UK

Medpace UK is a premier clinical research organization (CRO) headquartered in London, United Kingdom, with additional offices in Manchester and Edinburgh. As a wholly owned subsidiary of Medpace Holdings, Inc., the company specializes in full-service drug development, from early-phase trials through post-marketing studies. With over 30 years of industry experience, Medpace UK has earned a reputation for excellence in oncology, cardiovascular, metabolic, respiratory, and rare disease research. The company collaborates with global pharmaceutical companies, biotech firms, and academic institutions to accelerate the delivery of safe, effective therapies to patients.

Medpace UK stands out for its scientist-led approach, where medical and scientific experts directly oversee trial design and execution. This model ensures regulatory compliance, data quality, and patient safety. The company employs over 5,000 professionals worldwide, with approximately 1,200 based in the UK. In 2024, Medpace UK was recognised as one of the Top Workplaces in the UK by the Sunday Times, reflecting its employee-centric culture. The company’s revenue exceeded £1.2 billion in the last fiscal year, driven by a robust pipeline of over 200 active trials. Organizations of all sizes trust Medpace UK because of its proven track record in reducing trial timelines while maintaining the highest ethical standards. Whether it’s a small biotech seeking Phase I support or a multinational pharma requiring global Phase III management, Medpace UK delivers tailored solutions backed by deep therapeutic expertise.

Company History and Business Evolution

Medpace was founded in 1992 in Cincinnati, Ohio, by Dr. August Troendle, a physician and scientist who envisioned a CRO led by medical experts rather than purely business executives. The UK subsidiary, Medpace UK, was established in 1998 to serve the growing European market. Initially operating from a small office in London, the company expanded through organic growth and strategic acquisitions. A pivotal milestone came in 2005 when Medpace UK opened its dedicated cardiac safety laboratory in Manchester, becoming one of the first CROs to offer centralized ECG analysis. In 2010, the company acquired ClinResearch GmbH, strengthening its presence in Central and Eastern Europe. The 2016 acquisition of Shiloh Medical allowed Medpace UK to offer early-phase clinical services, including first-in-human trials. The company’s technology transformation began in 2018 with the launch of its proprietary eMedpace platform, integrating electronic data capture, trial management, and patient engagement tools. During the COVID-19 pandemic, Medpace UK played a critical role in vaccine and therapy trials, leveraging its agile infrastructure to support rapid enrollment. In 2022, it received the King’s Award for Enterprise in International Trade. Looking ahead, Medpace UK is investing in decentralized trial capabilities and artificial intelligence for patient recruitment. The company continues to be a top partner for the FDA and EMA, having contributed to the approval of over 50 new therapies in the past decade alone.

Medpace UK at a Glance

• Headquarters: London, United Kingdom (UK subsidiary of Medpace Holdings, Inc.)
• Founded: UK subsidiary established in 1998
• CEO: August Troendle, MD (Global CEO)
• UK Managing Director: Sarah Jenkins
• Industry: Clinical Research Organization (CRO) / Healthcare
• Employees: ~1,200 in the UK; 5,500+ globally
• Revenue (2024): £1.2 billion (global)
• Key Services: Early-phase to late-phase clinical trials, regulatory consulting, cardiac safety, central lab, biostatistics, data management, medical writing
• Therapeutic Focus: Oncology, cardiovascular, metabolic, respiratory, rare diseases, CNS, infectious diseases
• Geographic Reach: Over 45 countries through direct offices and partnerships
• Certifications: ISO 9001, ISO 27001, GCP compliant, FDA inspections cleared
• Awards: King’s Award for Enterprise (2022), Top Workplace UK (2024), CRO Leadership Award (2023)
• Technology: eMedpace platform, CTMS, EDC, ePRO, eCOA, RTSM
• Research Scale: Over 200 active clinical trials globally
• Patient Reach: 100,000+ patients enrolled to date
• Partnerships: Oxford University, NHS Trusts, Novartis, AstraZeneca, Roche
• Core Values: Scientific integrity, patient safety, teamwork, innovation, transparency
• Regulatory Approvals: Assisted in 50+ new drug approvals
• Sustainability: Carbon‑neutral operations by 2025 (target)
• Diversity: 40% of UK leadership are women; active LGBTQ+ and BAME networks

Mission, Vision, and Core Corporate Values

Medpace UK’s mission is to expedite the development of innovative therapies that improve global health while maintaining the highest ethical and scientific standards. The vision is to be the most trusted CRO partner, known for technical excellence and employee empowerment. Core values include scientific integrity – decisions are driven by data and clinical expertise, not commercial pressure. Patient safety is non‑negotiable; every trial is designed with the patient’s well‑being as the primary consideration. Teamwork is fostered across disciplines and geographies, breaking down silos to ensure seamless execution. Innovation encourages adoption of digital tools and novel methodologies to improve trial efficiency. Transparency requires honest communication with clients, regulators, and employees. These values are embedded in quarterly reviews, training programs, and annual awards such as the Excellence in Science recognition.

Business Strategy and Future Roadmap

Medpace UK’s growth strategy centres on three pillars: deep therapeutic expertise, technology-enabled efficiency, and global expansion. The company invests heavily in specialist training for project managers and clinical operations staff, ensuring that each team member possesses deep knowledge of their therapeutic area. The eMedpace platform is being enhanced with AI‑driven patient prescreening, automated data cleaning, and predictive analytics for site selection. In the next three years, Medpace UK plans to open new offices in Cambridge and Birmingham to tap into academic and biotech clusters. The company also aims to double its rare disease portfolio by partnering with patient advocacy groups. Decentralized clinical trials (DCTs) are a priority; Medpace UK is piloting virtual visits, wearable devices, and direct‑to‑patient drug delivery. The sustainability roadmap includes achieving carbon neutrality by 2025 through renewable energy procurement and virtual meeting adoption. By 2027, Medpace UK expects to increase revenue by 20% annually, driven by its reputation for on‑time delivery and regulatory success.

Products, Technologies, and Services

Medpace UK offers a comprehensive suite of services covering the entire drug development lifecycle. Key service lines include:

• Clinical Trial Management: Full‑service Phase I–IV studies with dedicated project managers, CRA teams, and medical monitors.
• Regulatory Affairs: Expertise in FDA, EMA, MHRA submissions, orphan drug applications, and paediatric investigation plans.
• Cardiac Safety: Centralized ECG analysis, Holter monitoring, and thorough QT studies using the Manchester lab.
• Central Laboratory: Sample processing, storage, and logistics with ISO‑certified facilities.
• Data Management & Biostatistics: CDISC‑compliant data collection, statistical analysis, and programming (SAS, R).
• Medical Writing: Clinical study reports, investigator brochures, informed consent forms, and publications.
• Technology Solutions: eMedpace platform integrates CTMS, EDC (Rave), ePRO, eCOA, IWRS, and safety database. Also provides patient engagement apps.
• Pharmacovigilance: Safety data management, signal detection, and aggregate reporting.
• Consulting: Feasibility studies, protocol design, site selection, and regulatory strategy.

These services are underpinned by robust quality systems and 24/7 helpdesk support for sites and clients. Medpace UK also offers flexible engagement models, from functional service provision (FSP) to full outsourced management.

Industries and Markets Served

Medpace UK primarily serves the pharmaceutical, biotechnology, and medical device industries. Additionally, it partners with academic research centers and government health agencies such as the National Institute for Health and Care Research (NIHR). Its therapeutic expertise spans oncology (solid tumors, haematology), cardiovascular (CAD, heart failure, arrhythmias), metabolic (diabetes, obesity, NASH), respiratory (asthma, COPD, IPF), rare diseases (Duchenne, SMA, ALS), CNS (Alzheimer’s, Parkinson’s, depression), and infectious diseases (HIV, hepatitis, COVID‑19). Geographically, Medpace UK manages trials across the UK, EU, and expanding into Asia and Latin America through partnerships. The company also has a dedicated biotech unit offering flexible, fast‑start services for small companies with limited resources.

Leadership and Management Philosophy

The UK leadership team is led by Sarah Jenkins (Managing Director), a veterinarian and PhD with 20 years in clinical research. She practices a servant leadership style, prioritizing employee development and open communication. Regular town halls and anonymous surveys ensure voice of the employee is heard. Managers are trained in emotional intelligence and conflict resolution. The philosophy centres on empowerment through expertise – clinical scientists are given autonomy to make decisions based on evidence, while administrative teams receive clear accountability. Mentorship programs pair junior CRAs with senior medical directors. The board reviews performance not only on revenue but also on employee engagement scores and client retention metrics. This approach has resulted in very low voluntary turnover (under 10% annually).

Corporate Events, Conferences, and Community Engagement

Medpace UK is a regular exhibitor at major industry events such as DIA Europe, Scrip Awards, and BIO International Convention. The company hosts an annual Innovation in Clinical Trials Summit in London, featuring keynotes from regulators and patient advocates. Employees participate in Medpace Cares volunteering days, partnering with charities like Macmillan Cancer Support and Parkinson’s UK. The company sponsors the UK Clinical Research Facility Network and provides scholarships for underrepresented minorities pursuing STEM degrees. Internally, the company runs wellness challenges, diversity panels, and a Recognition Program that rewards outstanding contributions. Most recently, Medpace UK participated in the London Marathon team raising over £50,000 for rare disease research.

Employees and Workplace Culture

Medpace UK fosters a collaborative, science-first culture where continuous learning is paramount. New hires undergo a comprehensive onboarding programme covering GCP, therapeutic area fundamentals, and company software. Employees have access to a learning management system with hundreds of courses, tuition reimbursement for advanced degrees, and opportunities to attend scientific conferences. The office environments are modern, with open-plan layouts, quiet zones, and breakout areas. Flexible hybrid working is standard for most roles. The company promotes well-being through an employee assistance programme, gym subsidies, and mental health first aiders. Diversity networks for women, LGBTQ+, and ethnic minorities are active and report to leadership. Compensation is competitive, with annual bonuses, pension contributions, and healthcare coverage. Annual employee satisfaction scores exceed 85%, making it a sought-after employer in the UK clinical research sector.

Job Details & Requirements for this Posting (Clinical Research Associate)

Role Overview

We are seeking a dedicated Clinical Research Associate (CRA) to join our UK team. In this role, you will be responsible for site management, ensuring that clinical trials are conducted in accordance with the protocol, GCP, and regulatory requirements. You will monitor site activities, verify data accuracy, and support investigator sites through the trial lifecycle.

Key Responsibilities

• Conduct initiation, interim, and close-out visits at study sites across the UK.
• Verify source documents versus case report forms (CRFs) for completeness and accuracy.
• Assess site compliance with ICH-GCP and applicable regulations.
• Collaborate with project managers, data managers, and medical monitors to resolve queries.
• Ensure timely submission of monitoring reports and follow-up letters.
• Maintain Investigator Site Files (ISF) and Trial Master File (TMF) documentation.
• Identify and escalate risks related to patient enrollment, data quality, or safety.
• Support site staff training on protocol amendments and new procedures.

Qualifications

• Bachelor’s degree in life sciences, nursing, or pharmacy (minimum 2:1).
• Minimum 1 year of on-site monitoring experience as a CRA.
• Excellent knowledge of ICH-GCP and UK regulatory framework (MHRA).
• Strong organizational skills and ability to manage multiple sites simultaneously.
• Full driving licence and willingness to travel (up to 60% within UK).
• Proficiency with CTMS, EDC (e.g., Rave, Medidata), and Microsoft Office.
• Excellent written and verbal communication skills in English.

Why Join Medpace UK?

• Work with a scientist-led team on innovative therapies that change lives.
• Competitive salary (£45,000–£60,000 based on experience) plus annual bonus.
• Comprehensive benefits: pension (8% employer contribution), private medical insurance, life assurance, 25 days holiday + bank holidays.
• Continuous professional development: access to CRA academy, leadership training, and external certifications.
• Hybrid working model (remote with site travel and monthly office days).
• Clear career progression: pathway to Senior CRA, Lead CRA, or Clinical Operations Manager.
• Recognition programmes and annual awards.

Customer Reviews and Industry Reputation (1200+ Words)

Medpace UK enjoys a strong reputation across multiple review platforms, reflecting its commitment to quality and employee satisfaction. Below is an exhaustive analysis based on aggregated feedback from current and former employees, clients, and partners.

Glassdoor

On Glassdoor, Medpace UK holds a rating of 4.2 out of 5 based on over 350 reviews. Approximately 78% of reviewers would recommend the company to a friend. Positive comments frequently highlight the scientific culture, supportive management, and emphasis on development. Typical praise includes: “Great place to grow as a CRA – you get real mentorship from medical directors” and “Work feels meaningful because we’re advancing therapies, not just hitting numbers.” Constructive feedback occasionally mentions high workload during peak periods and administrative tasks that could be streamlined. The CEO approval rating is 89%, well above industry average. Medpace UK responds to all negative reviews publicly, demonstrating a commitment to continuous improvement.

Indeed

Indeed shows an average rating of 4.0 out of 5 with more than 200 reviews. Employees praise the training programme and work-life balance, with many noting that the hybrid policy is effectively implemented. Common pros include “Great benefits package,” “Collaborative team atmosphere,” and “Opportunities to work on cutting-edge trials.” A few reviews mention that internal mobility can be slow, but the company recently launched a career framework to address this. The overall sentiment is positive, with many reviewers stating they would apply again.

Gartner Peer Insights

On Gartner Peer Insights, Medpace is rated 4.5 out of 5 as a CRO partner. Clients appreciate the regulatory expertise and on-time delivery. One review from a senior director at a mid-size pharma noted: “Medpace UK brought deep therapeutic knowledge that helped us avoid common pitfalls in cardiovascular studies.” Another comment highlighted the effectiveness of the eMedpace platform for real-time data access. The only area for improvement mentioned was responsiveness in certain therapeutic areas with niche requirements.

Trustpilot

Medpace UK has a Trustpilot score of 4.3 out of 5 with over 100 reviews. Most reviews are from employees who share positive experiences about the culture and benefits. A few from site staff mention that Medpace CRAs are professional and prepared. The company actively engages with reviewers, thanking them for feedback and addressing any concerns. Negative reviews are rare and often relate to specific site interaction issues that are quickly resolved.

G2

G2 reviews for Medpace are primarily focused on its technology solutions. The eMedpace platform receives an average rating of 4.1 out of 5. Users like the intuitive interface, especially the ePRO and eCOA modules. Some power users suggest more advanced reporting features. Overall, G2 reviewers agree that Medpace technology is reliable and well-supported by a responsive helpdesk.

Google Reviews

Medpace UK’s office locations have Google Maps ratings of 4.4 out of 5 (London) and 4.5 out of 5 (Manchester). Comments often highlight the modern office environment, free coffee, and convenient location near transport links. Employees appreciate the well-stocked kitchens and quiet rooms. A typical review: “Great place to work – management cares about your well-being and career.” External visitors – mainly site staff – note the professionalism during meetings.

LinkedIn Reputation

On LinkedIn, Medpace UK boasts over 40,000 followers. The company regularly posts thought leadership articles, career spotlights, and awards. The engagement rate is high, with employees frequently sharing content. The company’s LinkedIn profile highlights its culture, science-driven approach, and recent recognitions such as the King’s Award. Alumni often leave positive recommendations, reinforcing the employer brand.

Why Organizations Choose Medpace UK

Pharma and biotech organizations select Medpace UK for its proven ability to reduce trial cycle times while maintaining regulatory compliance. The scientist-led model ensures that protocol designs are medically sound, leading to fewer amendments. Clients also value the single-point-of-accountability from a dedicated project team that stays with the trial from start to finish. The centralised cardiac safety lab and global reach reduce the need for multiple vendors. Medpace UK’s strong relationships with UK sites (especially NHS trusts) facilitate faster site activation and patient recruitment. Additionally, the company offers flexible pricing models, including fixed-cost and risk-sharing arrangements. In an industry where speed and quality are paramount, Medpace UK delivers consistent results, as evidenced by its high client retention rate of over 90%.

Official Contact Information

For inquiries and assistance, please reach out to Medpace UK using the following contact details:

Address: Medpace UK, 10 Bloomsbury Way, London, WC1A 2SL, United Kingdom
Contact Number: +44 (0)20 7123 4567
Support Number: +44 (0)20 7123 4568
Helpdesk Number: +44 (0)800 123 4567
Website: www.medpace.com

Official Social Media Presence

• LinkedIn: @Medpace
• Twitter/X: @Medpace
• Facebook: @MedpaceUK
• YouTube: Medpace Channel (webinars and career videos)
• Instagram: @medpace_careers (employee stories)

SEO FAQ Section

Medpace UK provides full-service clinical trial management, regulatory affairs, cardiac safety, central laboratory, data management, biostatistics, medical writing, pharmacovigilance, and technology solutions through its eMedpace platform.

Medpace UK is headquartered in London, with additional offices in Manchester and Edinburgh.

Medpace UK employs approximately 1,200 people. Globally, Medpace has over 5,500 employees.

Based on reviews on Glassdoor and Indeed, Medpace UK is highly rated for its scientific culture, training, work-life balance, and benefits. It was named a Top Workplace in the UK in 2024.

For experienced CRAs, the salary typically ranges from £45,000 to £60,000 per year, plus bonus and benefits.

Yes, Medpace UK supports a hybrid work model for most roles, combining remote work with office attendance and site travel.

Medpace UK specializes in oncology, cardiovascular, metabolic, respiratory, rare diseases, CNS, and infectious diseases.

Through robust quality management systems, GCP compliance, eMedpace platform with built-in checks, and regular internal audits.

It is Medpace’s proprietary integrated platform combining CTMS, EDC, ePRO, eCOA, IWRS, and safety database.

Yes, Medpace UK has strong partnerships with NHS Trusts and the NIHR for clinical trial delivery.

CRAs can advance to Senior CRA, Lead CRA, Clinical Operations Manager, or Director roles, with structured training and mentorship.

Medpace UK offers an employee assistance programme, gym subsidies, mental health first aiders, and flexible working.

Medpace UK received the King’s Award for Enterprise (2022) and has been named a Top Workplace UK (2024) and CRO Leadership Award winner (2023).

Yes, Medpace UK is investing in DCT capabilities including virtual visits, wearables, and direct-to-patient drug delivery.

To expedite the development of innovative therapies that improve global health while maintaining the highest ethical and scientific standards.

Visit the careers page on Medpace’s official website or apply through LinkedIn job postings.

Yes, Medpace UK has a Clinical Research Graduate Programme and summer internships for life science students.

Medpace UK has active networks for women, LGBTQ+, and ethnic minorities, with 40% female leadership and inclusive hiring practices.

The company targets carbon neutrality by 2025 through renewable energy and virtual meeting adoption, with a dedicated sustainability team.

Absolutely. Medpace UK has a dedicated biotech unit offering flexible, fast-start services and risk-sharing pricing models.

For a comprehensive overview of Medpace UK and its services, alongside industry resources like Order Guest Posting Service, professionals can gain deeper insights into clinical trial best practices and corporate culture. This integrated resource hub supports informed decision-making for those exploring career opportunities or partnership with Medpace UK.